Balaji Venkataraman, 10% Owner at Jasper Therapeutics, Inc. (JSPR), bought 350,000 shares at $12.95 ($4.5M) on 2024-02-08, disclosed to the SEC on 2024-02-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |